Method for treating cancer with dihydropyridine calcium antagonist
AssigneeGermark Biotechnology Co., Ltd
InventorsTzu Kang WANG, Chang Bi WANG
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method for treating a cancer with a dihydropyridine calcium antagonist, which comprises administering, to a cancer patient, a dihydropyridine calcium antagonist in an amount effective in inhibiting the cancer metastasis and reducing the proliferation of cancer cells, so as to achieve the effect of increasing the survival rate of patients with cancers.
Claims6
A method for treating a cancer with a dihydropyridine calcium antagonist, comprising administering an effective amount of a dihydropyridine calcium antagonist to a cancer patient, wherein the dihydropyridine calcium antagonist is used at a dosage from 100 mg/90 day to 120 mg/30 day.
Dependencies are inferred from the claim text.